Victoria, BC, Canada – GenoLogics, a leading provider of laboratory information management system (LIMS) software specifically designed for complex genomics labs, today announced it has signed a worldwide co-selling agreement with Illumina, Inc. (NASDAQ: ILMN), a global leader in next-generation sequencing (NGS) instruments. Under terms of the deal, Illumina will market a version of the Geneus LIMS that is pre-configured for Illumina’s NGS instruments and TruSeq sample preparation kits.

The pre-configured Geneus LIMS software will enable Illumina’s NGS customers to accelerate implementations, track library preparations and instrument runs, and prepare basic reports in a matter of weeks, rather than months. Illumina sells its HiSeq and Genome Analyzer sequencing platforms and TruSeq sample preparation kits to genomics labs in academic institutions and commercial companies worldwide.

“We are pleased to announce this strategic agreement with our partner Illumina and we look forward to serving our joint customers as they initiate their next-generation sequencing research,” said GenoLogics Chief Executive Officer Michael Ball. “This agreement follows an earlier preferred partner agreement that has allowed us to work closely with Illumina on LIMS software that is complementary to their hardware and sample prep kits. This enables next-generation sequencing labs to deploy instrumentation and data management solutions simultaneously.”

Driven by an increase in sequencing time and a decrease in cost, the NGS market is expected to more than double, from $600 million in 2009 to $1.5 billion in 2014 (Scientia Advisors / Genetic Engineering & Biotechnology News). Yet, while researchers are gaining valuable knowledge from the massive amounts of data produced by NGS, they generally lack the information management technology to manage and analyze that data. In a recent survey by J.P. Morgan, 63 percent of NGS laboratory directors surveyed said that data storage, data management and informatics are the biggest hurdles to expanding next-generation sequencing.

The GenoLogics Geneus LIMS is designed specifically for genomics and NGS and allows researchers to automate workflows and easily trace samples and projects across multiple instruments and applications within one centralized system.

About GenoLogics

GenoLogics is a leading provider of laboratory information management system (LIMS) software specifically designed for genomics and next-generation sequencing (NGS) labs. The company’s flagship product Geneus eliminates the informatics bottlenecks that hinder sequencing workflows and analysis and allows labs to quickly adapt to changing protocols and technologies. Pre-configured for the major instrumentation platforms, Geneus enables easy and fast instrument integration and provides a highly flexible lab and data management system with end-to-end sample traceability, centralized project information, and smooth workflow management. Privately held GenoLogics was founded in 2003 and is based in Victoria, British Columbia. Its customers and partners are among the leading academic institutions and instrumentation companies worldwide.